v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity

Molecular and Cellular Biology

Volumn 20, Issue 7, 2000, Pages 2529-2542

  Clark, W ^a   Black, E J ^a   Maclaren, A ^a   Kruse, U ^a,b   Lathangue, N ^a,c   Vogt, P K ^a,d   Gillespie, D A F ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; HYBRID PROTEIN; MITOGENIC AGENT; ONCOPROTEIN; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHICK EMBRYO; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA SYNTHESIS; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ANIMALS; CARRIER PROTEINS; CDC2-CDC28 KINASES; CELL CYCLE; CELL DIVISION; CHICK EMBRYO; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; CYCLINS; FIBROBLASTS; G1 PHASE; MICROINJECTIONS; MITOGENS; ONCOGENE PROTEIN P65(GAG-JUN); ONCOGENE PROTEINS; PHOSPHORYLATION; PLASMIDS; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; S PHASE; TRANSFORMATION, GENETIC;

ANIMALIA;

EID: 0034100567     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.7.2529-2542.2000     Document Type: Article

References (51)

1. Amati, B., K. Alevizopoulos, and J. Vlach. 1998. Myc and the cell cycle. Front. Biosci. 3:D250-D268.
2. Bouchard, C., K. Thieke, A. Maier, R. Saffrich, J. Hanley-Hyde, W. Ansorge, S. Reed, P. Sicinski, J. Bartek, and M. Eilers. 1999. Direct induction of cyclin D2 by myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:5321-5333.
3. Buck, V., K. E. Allen, T. Sorensen, A. Bybee, E. M. Hijmans, P. M. Voorhoeve, R. Bernards, and N. B. La Thangue. 1995. Molecular and functional characterisation of E2F-5, a new member of the E2F family. Oncogene 11:31-38.
4. Clark, W., and D. A. Gillespie. 1997. Transformation hy v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors. Cell Growth Differ. 8:371-380.
5. Coats, S., W. M. Flanagan, J. Nourse, and J. M. Roberts. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880.
6. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
7. Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68.
8. Fu, S., I. Bottoli, M. Goller, and P. K. Vogt. 1999. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc. Natl. Acad. Sci. USA 96:5716-5721.
9. Fuerstenberg, S., H. Beug, M. Introna, K. Khazaie, A. Munoz, S. Ness, K. Nordstrom, J. Sap, L Stanley, M. Zenke, et al. 1990. Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector. J. Virol. 64:5891-5902.
10. Gao, M., I. Morgan, and P. K. Vogt 1996. Differential and antagonistic effects of v-Jun and c-Jun. Cancer Res. 56:4229-4235.
11. Girling, R., J. F. Partridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. La Thangue. 1993. A new component of the transcription factor DRTF1/E2F. Nature 362:83-87.
12. Hadman, M., L. Gabos, M. Loo, A. Sehgal, and T. J. Bos. 1996. Isolation and cloning of JTAP-1: a cathepsin like gene upregulated in response to V-Jun induced cell transformation. Oncogene 12:135-142.
13. Hadman, M., W. Lin, L. Bush, and T. J. Bos. 1998. Apolipoprotein A-1 is a negative target of v-Jun overexpression. Oncogene 16:655-660.
14. Hartl, M., and K. Bister. 1998. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun-or fos-induced fibroblast transformation. Oncogene 17:2901-2913.
15. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
16. Herber, B., M. Truss, M. Beato, and R. Muller. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-1304.
17. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
18. Hussain, S., A. Kilbey, and D. A. Gillespie. 1998. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter. Cell Growth Differ. 9:677-686.
19. Jansen-Durr, P. 1996. How viral oncogenes make the cell cycle. Trends Genet. 12:270-275.
20. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
21. Johnson, R. S., B. van Lingen, V. E. Papaioannou, and B. M. Spiegelman. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7:1309-1317.
22. Kilbey, A., E. J. Black, M. Unlu, and D. A. F. Gillespie. 1996. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. Oncogene 12:2409-2418.
23. Kovary, K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:4466-4472.
24. Kruse, U., J. S. Iacovoni, M. E. Goller, and P. K. Vogt. 1997. Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera. Proc. Natl. Acad. Sci. USA 94:12396-12400.
25. Lahti, J. M., H. Li, and V. J. Kidd. 1997. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J. Biol. Chem. 272:10859-10869.
26. La Rocca, S. A., D. H. Crouch, and D. A. Gillespie. 1994. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 9:3499-3508.
27. Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387-396.
28. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
29. Lukas, J., B. O. Petersen, K. Holm, J. Bartek, and K. Helin. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1047-1057.
30. Lundberg, A. S., and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
31. Maki, Y., T. J. Bos, C. Davis, M. Starbuck, and P. K. Vogt. 1987. Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl. Acad. Sci. USA 84:2848-2852.
32. May, G. H., M. Funk, E. J. Black, W. Clark, S. Hussain, J. R. Woodgett, and D. A. Gillespie. 1998. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo. Curr. Biol. 8:117-120.
33. Medema, R. H., R. E. Herrera, F. Lam, and R. A. Weinberg. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289-6293.
34. Mittnacht, S. 1998. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8:21-27.
35. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
36. Morgan, I. M., M. Asano, L. S. Havarstein, H. Ishikawa, T. Hiiragi, Y. Ito, and P. K. Vogt. 1993. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication. Oncogene 8:1135-1140.
37. Nead, M. A., L. A. Baglia, M. J. Antinore, J. W. Ludlow, and D. J. McCance. 1998. Rb binds c-Jun and activates transcription. EMBO J. 17:2342-2352.
38. Okamoto, A., D. J. Demetrick, E. A. Spillare, K. Hagiwara, S. P. Hussain, W. P. Bennett, K. Forrester, B. Gerwin, M. Serrano, D. H. Beach, et al. 1994. Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91:11045-11049.
39. Perez-Roger, I., S. H. Kim, B. Griffiths, A. Sewing, and H. Land. 1999. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18:5310-5320.
40. Pusch, O., G. Bernaschek, M. Eilers, and M. Hengstschlager. 1997. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene 15:649-656.
41. Rudolph, B., R. Saffrich, J. Zwicker, B. Henglein, R. Muller, W. Ansorge, and M. Eilers. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15:3065-3076.
42. Schreiber, M., A. Kolbus, F. Piu, A. Szabowski, U. Mohle-Steinlein, J. Tian, M. Karin, P. Angel, and E. F. Wagner. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13:607-619.
43. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
44. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
45. Shimizu, M., Y. Nomura, H. Suzuki, E. Ichikawa, A. Takeuchi, M. Suzuki, T. Nakamura, T. Nakajima, and K. Oda. 1998. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp. Cell Res. 239:93-103.
46. 1 cell state. Mol. Cell. Biol. 16:6965-6976.
47. Smith, M. J., and E. V. Prochownik. 1992. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood 79:2107-2115.
48. Steiner, P., A. Philipp, J. Lukas, D. Godden-Kent, M. Pagano, S. Mittnacht, J. Bartek, and M. Eilers. 1996. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J. 14:4814-4826.
49. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
50. Wisdom, R., R. S. Johnson, and C. Moore. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:188-197.
51. Zetterberg, A., O. Larsson, and K. G. Wiman. 1995. What is the restriction point? Curr. Opin. Cell Biol. 7:835-842.